Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Eksioglu, Erika A ^a   Zhu, Haizhen ^b   Bayouth, Lilly ^a   Bess, Jennifer ^a   Liu, Hong yan ^a   Nelson, David R ^a   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HUNAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEATH RECEPTOR 4; DEATH RECEPTOR 5; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; VIRUS ENVELOPE PROTEIN;

APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INNATE IMMUNITY; LIVER CELL; PROTEIN EXPRESSION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; CELL DEATH; CYTOLOGY; DRUG EFFECT; GENETICS; HOST PATHOGEN INTERACTION; LIVER; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIROLOGY;

HEPATITIS C VIRUS;

CELL DEATH; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DOWN-REGULATION; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; LIVER; PROTEIN BINDING; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOLL-LIKE RECEPTORS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 79959194569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021186     Document Type: Article

References (52)

1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH, (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132: 296-305.
2. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
3. Kanda T, Steele R, Ray R, Ray RB, (2007) Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol 81: 12375-12381.
4. Thomas A, Laxton C, Rodman J, Myangar N, Horscroft N, et al. (2007) Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother 51: 2969-2978.
5. Atencia R, Bustamante FJ, Valdivieso A, Arrieta A, Rinon M, et al. (2007) Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infect Dis 7: 136.
6. Villacres MC, Literat O, DeGiacomo M, Du W, Frederick T, et al. (2008) Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J Viral Hepat 15: 137-144.
7. Iwasaki A, Medzhitov R, (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
8. Malmgaard L, (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24: 439-454.
9. Servant MJ, Grandvaux N, Hiscott J, (2002) Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 64: 985-992.
10. Kawai T, Akira S, (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137.
11. Hiscott J, Lin R, Nakhaei P, Paz S, (2006) MasterCARD: a priceless link to innate immunity. Trends Mol Med 12: 53-56.
12. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
13. Barton GM, Medzhitov R, (2004) Toll signaling: RIPping off the TNF pathway. Nat Immunol 5: 472-474.
14. Natoli G, Austenaa LM, (2008) A birthday gift for TRADD. Nat Immunol 9: 1015-1016.
15. Thompson AJ, Locarnini SA, (2007) Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 85: 435-445.
16. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, et al. (2007) Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133: 1649-1659.
17. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
18. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
19. Zhu H, Nelson DR, Crawford JM, Liu C, (2005) Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J Interferon Cytokine Res 25: 528-539.
20. Zhu H, Butera M, Nelson D, Liu C, (2005) Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J 2: 80.
21. Zhu H, Shang X, Terada N, Liu C, (2004) STAT3 induces anti-hepatitis C viral activity in liver cells. Biochem Biophys Res Commun 324: 518-528.
22. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
23. Shang XZ, Zhu H, Lin K, Tu Z, Chen J, et al. (2004) Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest 84: 332-341.
24. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102: 2992-2997.
25. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
26. Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J, (1999) Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 19: 959-966.
27. Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, et al. (2009) Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 50: 198-206.
28. Yeruva S, Ramadori G, Raddatz D, (2008) NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 23: 305-317.
29. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
30. Bowie AG, Unterholzner L, (2008) Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8: 911-922.
31. Kaukinen P, Sillanpaa M, Kotenko S, Lin R, Hiscott J, et al. (2006) Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J 3: 66.
32. Miettinen M, Sareneva T, Julkunen I, Matikainen S, (2001) IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2: 349-355.
33. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
34. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, et al. (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol 83: 9824-9834.
35. Schroder M, Bowie AG, (2005) TLR3 in antiviral immunity: key player or bystander? Trends Immunol 26: 462-468.
36. Nishimura M, Naito S, (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28: 886-892.
37. Kawai T, Akira S, (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143: 1-20.
38. MacParland SA, Pham TN, Guy CS, Michalak TI, (2009) Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 49: 1431-1441.
39. Garcia M, Dogusan Z, Moore F, Sato S, Hartmann G, et al. (2009) Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells. Biochim Biophys Acta 1793: 1768-1775.
40. Kang DC, Gopalkrishnan RV, Lin L, Randolph A, Valerie K, et al. (2004) Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23: 1789-1800.
41. Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, et al. (2002) mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A 99: 637-642.
42. Mengshol JA, Golden-Mason L, Rosen HR, (2007) Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4: 622-634.
43. Bantel H, Schulze-Osthoff K, (2003) Apoptosis in hepatitis C virus infection. Cell Death Differ 10 (Suppl 1): S48-58.
44. Lai MM, (2002) Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 122: 568-571.
45. Afford SC, Adams DH, (2005) Following the TRAIL from hepatitis C virus and alcohol to fatty liver. Gut 54: 1518-1520.
46. Mundt B, Wirth T, Zender L, Waltemathe M, Trautwein C, et al. (2005) Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 54: 1590-1596.
47. Mundt B, Kuhnel F, Zender L, Paul Y, Tillmann H, et al. (2003) Involvement of TRAIL and its receptors in viral hepatitis. Faseb J 17: 94-96.
48. Li K, Chen Z, Kato N, Gale M Jr, Lemon SM, (2005) Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280: 16739-16747.
49. Eksioglu EA, Bess JR, Zhu H, Xu Y, Dong HJ, et al. (2009) Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat.
50. Weber F, (2007) Interaction of hepatitis C virus with the type I interferon system. World J Gastroenterol 13: 4818-4823.
51. Lee SH, Kim YK, Kim CS, Seol SK, Kim J, et al. (2005) E2 of hepatitis C virus inhibits apoptosis. J Immunol 175: 8226-8235.
52. Chang S, Kodys K, Szabo G, (2007) Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 51: 35-42.